Prudential Financial Inc. Sells 6,008 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Prudential Financial Inc. reduced its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 38.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 9,773 shares of the company's stock after selling 6,008 shares during the period. Prudential Financial Inc.'s holdings in HealthEquity were worth $963,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the stock. Arcadia Investment Management Corp MI bought a new stake in HealthEquity in the 4th quarter valued at about $26,000. Smartleaf Asset Management LLC raised its position in shares of HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after purchasing an additional 98 shares during the period. Proficio Capital Partners LLC purchased a new stake in shares of HealthEquity during the 4th quarter valued at approximately $39,000. UMB Bank n.a. lifted its stake in shares of HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after buying an additional 164 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ boosted its holdings in HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock worth $45,000 after buying an additional 445 shares during the period. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. The trade was a 13.55 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 20,381 shares of company stock valued at $1,781,432. Corporate insiders own 2.20% of the company's stock.

Remove Ads

HealthEquity Price Performance

NASDAQ:HQY traded up $2.26 during midday trading on Friday, hitting $82.20. The company had a trading volume of 926,462 shares, compared to its average volume of 759,548. The company has a market capitalization of $7.11 billion, a PE ratio of 75.41, a P/E/G ratio of 1.60 and a beta of 0.49. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The stock's fifty day moving average price is $97.63 and its 200-day moving average price is $96.30.

Analyst Ratings Changes

Several research firms have issued reports on HQY. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their target price for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. KeyCorp dropped their price objective on HealthEquity from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Monday, March 24th. Wells Fargo & Company lifted their target price on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. Barrington Research reiterated an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a research report on Friday. Finally, The Goldman Sachs Group cut their price objective on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus target price of $112.58.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.